Expertise in
4
conditions

Ramy Rahme

Paris, FR 
Expertise in
4
conditions
Paris, FR 

Overview

Ramy Rahme practices practicing medicine in Paris, France.

Mr. Rahme is highly rated in 4 conditions, according to our data. His clinical expertise encompasses Acute Myeloid Leukemia (AML), Acute Promyelocytic Leukemia, Leukemia, and Myelodysplastic Syndrome (MDS).

He is actively involved in clinical research, co-authoring 29 peer reviewed articles.

Gender

Male

Locations

Paris, France
Other Locations
Bobigny, 93000, France
Creteil, France

Frequently Asked Questions about Ramy Rahme

Is Ramy Rahme a top-rated expert for Acute Myeloid Leukemia (AML)?

MediFind is an objective health platform that identifies experts based on real-world data. Ramy Rahme is classified as an Advanced expert for Acute Myeloid Leukemia (AML), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Ramy Rahme participate in research or clinical trials?

Yes. Ramy Rahme has published 29 articles and abstracts on conditions like Acute Myeloid Leukemia (AML). You can view a list of Ramy Rahme's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Rahme's expertise for a condition
ConditionClose
      View All 8 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile